|
Market Closed -
London S.E.
11:35:03 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.1300 GBX | -3.70% |
|
-10.34% | -61.19% |
| 09-15 | EARNINGS AND TRADING: Amcomri revenue up; Unicorn Namibia acquisition | AN |
| 09-15 | ValiRx plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.38M | - | - | - | - | - |
| 74.27B | |||||
| 61.21B | |||||
| 27.55B | |||||
| 26.38B | - | ||||
| 25.34B | - |
- Stock Market
- Stocks
- VAL Stock
- Charts ValiRx plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
